Winrevair, when added to standard of care, reduced clinical worsening events by 76% in adults recently diagnosed with PAH, trial data show.

Stem cell-derived conditioned medium, the liquid that remains after cells are cultured, reduced PAH signs in rats and cells, per a study.

Gossamer Bio has begun the process of acquiring Respira Therapeutics and its lead on-demand PH treatment candidate, RT234.

Columnist Jolie Lizana attended the Pulmonary Hypertension Association's (PHA) PHPN Symposium, which discussed PH research.

Higher pulmonary arterial pressure in pregnant women with PH was linked to longer hospitalizations, and ICU admission, in a long-term study.

As a PH patient and transplant recipient, columnist Anna Jeter relies on her care team when it comes to vaccine recommendations.

Stanford University has been awarded a grant from the U.S. National Institutes of Health (NIH) to begin a Phase 2 clinical trial of pulmonary arterial hypertension (PAH) treatment tiprelestat, the ...

United Therapeutics and Mannkind Corporation are teaming up to develop a new inhaled therapy for pulmonary hypertension. The two companies worked together to develop Tyvaso DPI, a dry powder ...

Corvista Health’s point-of-care device can detect cases of pulmonary hypertension (PH) that other noninvasive diagnostic tools miss, according to a recent case series. “By enabling physicians to ...